Prothena Corp Public (PRTA) Other financing activities (2014 - 2023)

Prothena Corp Public (PRTA) recorded quarterly Other financing activities of $40000.0 in Q1 2023, down 73.51% quarter-over-quarter from $151000.0 in Q1 2022, and down 73.51% on a YoY basis from $151000.0 in Q1 2022.

Prothena Corp Public (PRTA) Other financing activities (2014 - 2023) Analysis & Trends

Prothena Corp Public's Other financing activities history runs 5 years deep, the most recent figure standing at $40000.0 for Q1 2023.

  • In Q1 2023, Other financing activities fell 73.51% year-over-year to $40000.0; the TTM figure through Mar 2023 stood at $910000.0 (down 15.27% YoY), while the FY2016 annual figure was $1.0 million, down 73.57% from the prior year.
  • Other financing activities was $40000.0 for Q1 2023 at Prothena Corp Public, down from $151000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $151000.0 in Q1 2022 to a low of $40000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Prothena Corp Public 479.08 Mn 149.61 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 40,000.00
Mar 31, 2023 40,000.00
Mar 31, 2022 151,000.00
Mar 31, 2022 151,000.00
Dec 31, 2016 192,000.00
Dec 31, 2016 192,000.00
Sep 30, 2016 527,000.00
Sep 30, 2016 527,000.00
Jun 30, 2016 204,000.00
Jun 30, 2016 204,000.00
Mar 31, 2016 96,000.00
Mar 31, 2016 96,000.00
Dec 31, 2015 1.50 Mn
Dec 31, 2015 1.50 Mn
Sep 30, 2015 1.36 Mn
Sep 30, 2015 1.36 Mn
Jun 30, 2015 599,000.00
Jun 30, 2015 599,000.00
Mar 31, 2015 390,000.00
Mar 31, 2015 390,000.00